Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced or Metastatic Solid Tumors × AZD 6244 × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumours 5 Solid Tumors 1 Locally Advanced or Metastatic Solid Tumors 1

Interventions

pembrolizumab 3 toripalimab 2 tislelizumab 1 spartalizumab 1 sintilimab 1 efineptakin alfa 1 camrelizumab 1 atezolizumab 1 Taxes 1 MK 2206 1 Cyclophosphamide 1 Cetuximab 1 Albumin-Bound Paclitaxel 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01021748 2018-08-07

A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)

Merck Sharp & Dohme LLC

Phase 1 Completed

63 enrolled 17 charts

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡